Dynavax Technologies
DVAX
#4890
Rank
A$2.69 B
Marketcap
A$22.93
Share price
38.19%
Change (1 day)
9.79%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -A$58.75 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are A$0.33 Billion. In 2024 the company made an earning of A$56.12 Million, an increase over its 2023 earnings that were of A$3.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$58.75 Million-204.66%
2024 A$56.12 M1475.31%
2023 A$3.56 M-99.2%
2022 A$0.44 B238.78%
2021 A$0.13 B-257.89%
2020 -A$83.76 Million-58.58%
2019 -A$0.21 Billion-9.32%
2018 -A$0.23 Billion60.44%
2017 -A$0.14 Billion-15.8%
2016 -A$0.17 Billion4.22%
2015 -A$0.16 Billion16.54%
2014 -A$0.14 Billion37.09%
2013 -A$99.13 Million
2010 -A$70.95 Million214.85%
2009 -A$22.54 Million-37.33%
2008 -A$35.96 Million-66.07%
2007 -A$0.11 Billion16.92%
2006 -A$90.65 Million170.36%
2005 -A$33.53 Million33.39%
2004 -A$25.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
A$30.8 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.83 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.42 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.73 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.51 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
A$13.89 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$17.66 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.64 B-5,328.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$12.29 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA